LoadingLoadingLoadingThe quick read
Price is syncing.
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Aethlon Medical Inc (AEMD) insiders filed no open-market purchases or sales in the 90 days to Oct 14, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a AEMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
2 funds hold a position.
No tracked top-trader positions in AEMD right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 12, 2026
Period ending
Jun 30, 2026
Earnings per share
-$4.05 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 12, 2026 | -$4.02 / -$4.05Alpha Vantage | +0.74% in line | Unavailable | Unavailable |
| Mar 31, 2026 | Jun 10, 2026 | -$1.20 / -$2.45Alpha Vantage | +51.03% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | -$2.45 / -$2.01Alpha Vantage | -21.89% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 12, 2025 | -$3.74 / -$3.66Alpha Vantage | -2.19% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 13, 2025 | -$8.50 / -$7.30Alpha Vantage | -16.44% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Jun 26, 2025 | -$3.44 / -$1.11Alpha Vantage | -$2.33 miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | -$10.40 / -$16.27Alpha Vantage | +36.08% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 13, 2024 | -$16.00 / -$15.60Alpha Vantage | -2.56% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
This company is running thin margins.
Valuation
Quality
Growth
Market data unavailable.
